CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-23 | FOEHR MATTHEW W President and COO | Option exercise · Employee Stock Option (right to buy) | −5,444 | 54,556 | ||
| 2018-02-15 | Berkman Charles S SVP, Gen. Counsel & Secretary | Shares withheld for taxes | −524 | $157.18 | $82K | 25,571 |
| 2018-02-15 | Berkman Charles S SVP, Gen. Counsel & Secretary | Shares withheld for taxes | −252 | $157.18 | $40K | 25,319 |
| 2018-02-15 | Berkman Charles S SVP, Gen. Counsel & Secretary | Shares withheld for taxes | −260 | $157.18 | $41K | 25,059 |
| 2018-02-15 | FOEHR MATTHEW W President and COO | Shares withheld for taxes | −1,511 | $157.18 | $237K | 96,983 |
| 2018-02-15 | FOEHR MATTHEW W President and COO | Shares withheld for taxes | −906 | $157.18 | $142K | 96,077 |
| 2018-02-15 | FOEHR MATTHEW W President and COO | Shares withheld for taxes | −1,246 | $157.18 | $196K | 94,831 |
| 2018-02-15 | HIGGINS JOHN L Chief Executive Officer | Sale | −9,000 | $157.03 | $1.4M | 102,700 |
| 2018-02-15 | HIGGINS JOHN L Chief Executive Officer | Shares withheld for taxes | −2,635 | $157.18 | $414K | 100,065 |
| 2018-02-15 | HIGGINS JOHN L Chief Executive Officer | Shares withheld for taxes | −1,918 | $157.18 | $301K | 98,147 |
| 2018-02-15 | HIGGINS JOHN L Chief Executive Officer | Shares withheld for taxes | −1,689 | $157.18 | $265K | 96,458 |
| 2018-02-15 | Korenberg Matthew E EVP,Finance & Strategy and CFO | Shares withheld for taxes | −354 | $157.18 | $56K | 10,013 |
| 2018-02-15 | Korenberg Matthew E EVP,Finance & Strategy and CFO | Shares withheld for taxes | −326 | $157.18 | $51K | 9,687 |
| 2018-01-24 | HIGGINS JOHN L Chief Executive Officer | Sale | −22,500 | $165.00 | $3.7M | 111,700 |
| 2018-01-19 | HIGGINS JOHN L Chief Executive Officer | Option exercise | +16,249 | $16.14 | $262K | 162,299 |
| 2018-01-19 | HIGGINS JOHN L Chief Executive Officer | Sale | −16,249 | $155.00 | $2.5M | 146,050 |
| 2018-01-19 | HIGGINS JOHN L Chief Executive Officer | Sale | −11,850 | $151.92 | $1.8M | 134,200 |
| 2018-01-19 | HIGGINS JOHN L Chief Executive Officer | Option exercise · Incentive Stock Option (right to buy) | −16,249 | 42,195 | ||
| 2018-01-10 | KOZARICH JOHN W Director | Sale | −2,500 | $145.00 | $363K | 33,149 |
| 2017-12-28 | Korenberg Matthew E VP, Finance and CFO | Grant or award | +3,750 | 11,897 |
Page 54 of 55 · 1,097 trades